|
|
|
Volumn 10, Issue SUPPL. 3, 2012, Pages 12-15
|
|
Mastering industrialization of cell therapy products: An opportunity for dedicated CMOs
a
a
a
MaSTherCell
*
(Belgium)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER VACCINE;
CELL THERAPY AGENT;
CHONDROCYTE IMPLANT;
SIPULEUCEL T;
VIRUS VECTOR;
ADENOSINE DEAMINASE DEFICIENCY;
BIOMEDICAL ENGINEERING;
BIOREACTOR EQUIPMENT;
BLOOD DISEASE;
CELL THERAPY;
COMMERCIAL PHENOMENA;
CONTAMINATION;
COST EFFECTIVENESS ANALYSIS;
DIABETES MELLITUS;
DISEASE TRANSMISSION;
DRUG APPROVAL;
DRUG MARKETING;
EX VIVO GENE TRANSFER;
FIBROBLAST;
FOOD AND DRUG ADMINISTRATION;
GENE SEQUENCE;
GOOD MANUFACTURING PRACTICE;
GROWTH RATE;
HEMATOPOIETIC STEM CELL;
HUMAN;
IMMUNOTHERAPY;
INDUSTRIALIZATION;
MEDICAL DOCUMENTATION;
MESENCHYMAL STEM CELL;
METACHROMATIC LEUKODYSTROPHY;
NERVE CELL;
PRODUCT DEVELOPMENT;
PROSTATE CANCER;
REGENERATIVE MEDICINE;
RISK ASSESSMENT;
SHORT SURVEY;
STAFF TRAINING;
TISSUE REGENERATION;
UMBILICAL CORD BLOOD;
VALIDATION PROCESS;
WASTE MANAGEMENT;
WISKOTT ALDRICH SYNDROME;
|
|
EID: 84863558433
PISSN: 15426319
EISSN: None
Source Type: Trade Journal
DOI: None Document Type: Short Survey |
|
Times cited : (9)
|
|
References (2)
|
